Blog
Remote Working Offers Employees More Life Opportunities
PRA Health Sciences is proud of the collective resilience our employees have shown in overcoming these challenges as we continue to serve our…
Featured Insights
Ask the Experts: Understanding Juvenile Idiopathic Arthritis
In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
PRA Teams with Microsoft to Enhance COVID-19 Monitoring
Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…
All Insights
Blog
Newsletter
Rare Disease Newsletter
This quarterly publication will keep you informed about key news in the world of rare disease clinical research and update you on what the PRA Health…
Blog
Ask the Experts: Understanding Juvenile Idiopathic Arthritis
In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
Newsletter
Global Clinical Regulatory Services Newsletter
This quarterly eNewsletter will keep you informed of regulatory news and trends as it relates to the clinical development industry and insights from…
Newsletter
Industry Watch
In the second week of July, we bring you news of developments in HIV research, as well as updates on immunotherapies, Alzheimer’s disease,…
Newsletter
Industry Watch
In the first week of July we bring you news of research into the use of ultrasound to treat conditions such as depression, migraine, and…
White Paper
Global Pediatric Drug Development Collaboration Part Two
70% of medicines given to children have never been studied in pediatric populations. Children who need treatments represent a relatively small…
White Paper
Global Pediatric Drug Development Collaboration Part One
The pharmaceutical industry is unlike any other industry in that the products manufactured can dramatically improve, and even save, lives. This is…
Newsletter
Virtual Trials and the Regulatory Puzzle
Where is that one guideline providing all regulatory considerations for virtual trials? The one document that clearly describes all requirements…
Newsletter
Virtual Trials: Benefits & Challenges
Compared to traditional study models, the strength of the virtual trials concept is the ability to make it easier to include patients from diverse…